In fact, inhibition of IL-34 increased the sensitivity of colon tumor cells to oxaliplatin, suggesting that IL-34 may act as a pro-inflammatory and pro-tumorigenic factor in IBD disease and colorectal carcinomas 56. This evidence concerns the gene IL34 and colorectal carcinoma.